<--- Back to Details
First PageDocument Content
Investment / Activist shareholder / Corporate governance / Bill Ackman / Darden Restaurants / Allergan / Olive Garden / Value investing / Valeant Pharmaceuticals / Financial economics / Finance / Business
Date: 2014-05-01 10:51:57
Investment
Activist shareholder
Corporate governance
Bill Ackman
Darden Restaurants
Allergan
Olive Garden
Value investing
Valeant Pharmaceuticals
Financial economics
Finance
Business

Activists Wept for There Were No More Worlds to Conquer Wall Street Journal By Dennis K. Berman April 22, 2014

Add to Reading List

Source URL: www.law.harvard.edu

Download Document from Source Website

File Size: 86,80 KB

Share Document on Facebook

Similar Documents

      Valeant Pharmaceuticals International, Inc.  400 Somerset Corporate Boulevard, Bridgewater, NJ 08807 

DocID: 1rD6j - View Document

Business / Economy / Health care / Gilead Sciences / Specialty drugs / Pharmaceuticals policy / Tenofovir alafenamide / Valeant Pharmaceuticals / Tenofovir disoproxil / Rilpivirine / Pharmaceutical industry in China / AstraZeneca

March 4, 2016 BUSY WEEK? Here are the TOP INDUSTRY NEWS stories you might have missed, as selected by DCAT Editorial Director Patricia Van Arnum. Sponsored By:

DocID: 1rdax - View Document

Business / Economy / Biotechnology / CAC 40 / Sanofi / AstraZeneca / Novartis / Takeda Pharmaceutical Company / Valeant Pharmaceuticals / Pharmaceutical industry in China / Bausch & Lomb / Pharmaceutical industry in India

February 5, 2016 BUSY WEEK? Here are the TOP INDUSTRY NEWS stories you might have missed, as selected by DCAT Editorial Director Patricia Van Arnum.  Sponsored By:

DocID: 1r6rO - View Document

S&P/TSX 60 Index / S&P/TSX Composite Index / Valeant Pharmaceuticals / Arbutin / Skin whitening / TSX / Sirona / Hydroquinone / SBM / Economy of Canada / Economy / Religion

Investor Presentation Jan 31, 2016 TM TSX-V: SBM

DocID: 1r4gv - View Document

Economy / Finance / Money / Investment / Financial ratios / Mathematical finance / Stock market / Valuation / Rate of return / Ruane /  Cunniff & Goldfarb / Valeant Pharmaceuticals / Earnings growth

Sequoia Fund, Inc. ANNUAL REPORT DECEMBER 31, 2013

DocID: 1qfcU - View Document